Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 38, 2008 - Issue 3
205
Views
31
CrossRef citations to date
0
Altmetric
Research Article

Urinary excretion of the main metabolites of 3,4-methylenedioxymethamphetamine (MDMA), including the sulfate and glucuronide of 4-hydroxy-3-methoxymethamphetamine (HMMA), in humans and rats

, , , , , , , , & show all
Pages 314-324 | Received 02 Oct 2007, Accepted 12 Nov 2007, Published online: 22 Sep 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Kenji Tsujikawa, Toshiyasu Mikuma, Kenji Kuwayama, Hajime Miyaguchi, Tatsuyuki Kanamori, Yuko T. Iwata & Hiroyuki Inoue. (2011) Urinary excretion profiles of N-hydroxy-3,4-methylenedioxymethamphetamine in rats. Xenobiotica 41:7, pages 578-584.
Read now

Articles from other publishers (30)

Yang Chen, Libo Zhang, Zengbo Ding, Xianwen Wu, Guibin Wang & Jie Shi. (2022) Effects of 3-methylmethcathinone on conditioned place preference and anxiety-like behavior: Comparison with methamphetamine. Frontiers in Molecular Neuroscience 15.
Crossref
Anny Talita M. da Silva, Carliani Dal Piero B. Bessa, Warley de S. Borges & Keyller B. Borges. (2018) Bioanalytical methods for determining ecstasy components in biological matrices: A review. TrAC Trends in Analytical Chemistry 108, pages 323-346.
Crossref
Kei Zaitsu. 2018. Synthetic Cathinones. Synthetic Cathinones 71 96 .
Lilian H.J. Richter, Veit Flockerzi, Hans H. Maurer & Markus R. Meyer. (2017) Pooled human liver preparations, HepaRG, or HepG2 cell lines for metabolism studies of new psychoactive substances? A study using MDMA, MDBD, butylone, MDPPP, MDPV, MDPB, 5-MAPB, and 5-API as examples. Journal of Pharmaceutical and Biomedical Analysis 143, pages 32-42.
Crossref
Elli Tyrkkö, Mikael Andersson & Robert Kronstrand. (2016) The Toxicology of New Psychoactive Substances. Therapeutic Drug Monitoring 38:2, pages 190-216.
Crossref
Andrea E. Steuer, Corina Schmidhauser, Matthias E. Liechti & Thomas Kraemer. (2015) Development and validation of an LC-MS/MS method after chiral derivatization for the simultaneous stereoselective determination of methylenedioxy-methamphetamine (MDMA) and its phase I and II metabolites in human blood plasma. Drug Testing and Analysis 7:7, pages 592-602.
Crossref
Xueguo Chen. (2015) Simultaneous determination of four designer drugs and their major metabolites by liquid chromatography–mass spectrometry. Journal of Chromatography B 992, pages 1-7.
Crossref
Jessica Welter, Markus R. Meyer, Pierce Kavanagh & Hans H. Maurer. (2014) Studies on the metabolism and the detectability of 4-methyl-amphetamine and its isomers 2-methyl-amphetamine and 3-methyl-amphetamine in rat urine using GC-MS and LC-(high-resolution)-MS n. Analytical and Bioanalytical Chemistry 406:7, pages 1957-1974.
Crossref
Marta Concheiro, Michael H. Baumann, Karl B. Scheidweiler, Richard B. Rothman, Gina F. Marrone & Marilyn A. Huestis. (2014) Nonlinear Pharmacokinetics of (±)3,4-Methylenedioxymethamphetamine (MDMA) and Its Pharmacodynamic Consequences in the Rat. Drug Metabolism and Disposition 42:1, pages 119-125.
Crossref
Kei Zaitsu, Munehiro Katagi, Hitoshi Tsuchihashi & Akira Ishii. (2013) Recently abused synthetic cathinones, α-pyrrolidinophenone derivatives: a review of their pharmacology, acute toxicity, and metabolism. Forensic Toxicology 32:1, pages 1-8.
Crossref
Keiko Nakanishi, Munehiro Katagi, Kei Zaitsu, Noriaki Shima, Hiroe Kamata, Akihiro Miki, Hajime Kato, Ken-Ichi Harada, Hitoshi Tsuchihashi & Koichi Suzuki. (2012) Simultaneous enantiomeric determination of MDMA and its phase I and phase II metabolites in urine by liquid chromatography–tandem mass spectrometry with chiral derivatization. Analytical and Bioanalytical Chemistry 404:8, pages 2427-2435.
Crossref
Kenji Kuwayama, Kenji Tsujikawa, Hajime Miyaguchi, Tatsuyuki Kanamori, Yuko T. Iwata & Hiroyuki Inoue. (2011) Interaction of 3,4‐Methylenedioxymethamphetamine and Methamphetamine During Metabolism by In Vitro Human Metabolic Enzymes and in Rats* . Journal of Forensic Sciences 57:4, pages 1008-1013.
Crossref
Keiko Nakanishi, Akihiro Miki, Kei Zaitsu, Hiroe Kamata, Noriaki Shima, Tooru Kamata, Munehiro Katagi, Michiaki Tatsuno, Hitoshi Tsuchihashi & Koichi Suzuki. (2012) Cross-reactivities of various phenethylamine-type designer drugs to immunoassays for amphetamines, with special attention to the evaluation of the one-step urine drug test Instant-View™, and the Emit® assays for use in drug enforcement. Forensic Science International 217:1-3, pages 174-181.
Crossref
Andrea E. Schwaninger, Markus R. Meyer, Allan J. Barnes, Erin A. Kolbrich-Spargo, David A. Gorelick, Robert S. Goodwin, Marilyn A. Huestis & Hans H. Maurer. (2012) Stereoselective urinary MDMA (ecstasy) and metabolites excretion kinetics following controlled MDMA administration to humans. Biochemical Pharmacology 83:1, pages 131-138.
Crossref
Kenji Kuwayama, Kenji Tsujikawa, Hajime Miyaguchi, Tatsuyuki Kanamori, Yuko T. Iwata & Hiroyuki Inoue. (2011) Rapid, simple, and highly sensitive analysis of drugs in biological samples using thin-layer chromatography coupled with matrix-assisted laser desorption/ionization mass spectrometry. Analytical and Bioanalytical Chemistry 402:3, pages 1257-1267.
Crossref
Andrea E Schwaninger, Markus R Meyer, Allan J Barnes, Erin A Kolbrich-Spargo, David A Gorelick, Robert S Goodwin, Marilyn A Huestis & Hans H Maurer. (2011) Urinary Excretion Kinetics of 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) and Its Phase I and Phase II Metabolites in Humans following Controlled MDMA Administration. Clinical Chemistry 57:12, pages 1748-1756.
Crossref
Andrea E. Schwaninger, Markus R. Meyer & Hans H. Maurer. (2011) Investigation on the Enantioselectivity of the Sulfation of the Methylenedioxymethamphetamine Metabolites 3,4-Dihydroxymethamphetamine and 4-Hydroxy-3-Methoxymethamphetamine using the Substrate-Depletion Approach. Drug Metabolism and Disposition 39:11, pages 1998-2002.
Crossref
Usman Khan & Jim A. Nicell. (2011) Refined sewer epidemiology mass balances and their application to heroin, cocaine and ecstasy. Environment International 37:7, pages 1236-1252.
Crossref
Andrea E. Schwaninger, Markus R. Meyer, Marilyn A. Huestis & Hans H. Maurer. (2011) Development and validation of LC-HRMS and GC-NICI-MS methods for stereoselective determination of MDMA and its phase I and II metabolites in human urine. Journal of Mass Spectrometry 46:7, pages 603-614.
Crossref
Hans H Maurer. (2010) Chemistry, Pharmacology, and Metabolism of Emerging Drugs of Abuse. Therapeutic Drug Monitoring 32:5, pages 544-549.
Crossref
Daniel Gomes, Paula Guedes de Pinho, Helena Pontes, Luísa Ferreira, Paula Branco, Fernando Remião, Félix Carvalho, M. Lurdes Bastos & Helena Carmo. (2010) Gas chromatography–ion trap mass spectrometry method for the simultaneous measurement of MDMA (ecstasy) and its metabolites, MDA, HMA, and HMMA in plasma and urine. Journal of Chromatography B 878:9-10, pages 815-822.
Crossref
Kei Zaitsu, Munehiro Katagi, Keiko Nakanishi, Tooru Kamata, Noriaki Shima, Hiroe Kamata, Reiko I. Ishimaru, Yoshiaki Iwamuro, Satoshi Chinaka, Nariaki Takayama, Akihiro Miki & Hitoshi Tsuchihashi. (2010) Comprehensive Analytical Procedures for the Unequivocal Determination of a Newly Encountered Drug “N-hydroxy-3,4-methylenedioxymethamphetamine (N-OH-MDMA)”. Japanese Journal of Forensic Science and Technology 15:1, pages 25-37.
Crossref
Tooru Kamata, Munehiro Katagi, Keiko Nakanishi, Kei Zaitsu, Noriaki Shima, Hiroe Kamata, Akihiro Miki & Hitoshi Tsuchihashi. (2010) Metabolism and Urinary Excretion of N-Hydroxy-3,4-methylenedioxymethamphetamine, a Recently Banned Narcotic in Japan. Japanese Journal of Forensic Science and Technology 15:1, pages 15-23.
Crossref
Andrea E. Schwaninger, Markus R. Meyer, Josef Zapp & Hans H. Maurer. (2009) The Role of Human UDP-Glucuronyltransferases on the Formation of the Methylenedioxymethamphetamine (Ecstasy) Phase II Metabolites R - and S -3-Methoxymethamphetamine 4- O -Glucuronides . Drug Metabolism and Disposition 37:11, pages 2212-2220.
Crossref
Kei Zaitsu, Munehiro Katagi, Hiroe T. Kamata, Tooru Kamata, Noriaki Shima, Akihiro Miki, Hitoshi Tsuchihashi & Yasushige Mori. (2009) Determination of the metabolites of the new designer drugs bk-MBDB and bk-MDEA in human urine. Forensic Science International 188:1-3, pages 131-139.
Crossref
Melanie Mueller, Erin A. Kolbrich-Spargo, Frank T. Peters, Marilyn A. Huestis, George A. Ricaurte & Hans H. Maurer. (2009) Hydrolysis of 3,4-methylenedioxymethamphetamine (MDMA) metabolite conjugates in human, squirrel monkey, and rat plasma. Analytical and Bioanalytical Chemistry 393:6-7, pages 1607-1617.
Crossref
Noriaki Shima, Munehiro Katagi & Hitoshi Tsuchihashi. (2009) Direct Analysis of Conjugate Metabolites of Methamphetamine, 3,4-Methylenedioxymethamphetamine, and Their Designer Drugs in Biological Fluids. Journal of Health Science 55:4, pages 495-502.
Crossref
Karl B. Scheidweiler, Allan J. Barnes & Marilyn A. Huestis. (2008) A validated gas chromatographic–electron impact ionization mass spectrometric method for methamphetamine, methylenedioxymethamphetamine (MDMA), and metabolites in mouse plasma and brain. Journal of Chromatography B 876:2, pages 266-276.
Crossref
Noriaki Shima, Munehiro Katagi, Hiroe Kamata, Kei Zaitsu, Tooru Kamata, Akihiro Miki, Hitoshi Tsuchihashi, Tsutomu Sakuma & Nobuo Nemoto. (2008) Conjugates of p-hydroxymethamphetamine and 4-hydroxy-3-methoxymethamphetamine in blood obtained from methamphetamine and 3,4-methylenedioxymethamphetamine users: analysis by LC-MS-MS. Forensic Toxicology 26:2, pages 58-65.
Crossref
Nasrin Akhter, Sachiko Tanaka, Takashi Ashino, Noriaki Shima, Munehiro Katagi, Hitoshi Tsuchihashi, Anower Hussain Mian, Satoshi Numazawa & Takemi Yoshida. (2008) In vivo study on the roles of cytochrome P450 enzymes for metabolism of 3,4-methylenedioxymethamphetamine (Ecstasy) in rats. Forensic Toxicology 26:2, pages 52-57.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.